To further investigate the role of candidate genes in mediating immunotherapy response, we analyzed their expression in GSE154538, a dataset consisting of advanced CRC patients with high TMB who were treated with the anti-PD-1 monoclonal antibody (nivolumab). The gene discussed is PDCD1; the disease is colorectal carcinoma.